Welcome to the Pelvic Health Explorer’s monthly article. This is part 2 of a 3-part series on clinical aspects of GERD and the role of the Pelvic Health Provider in management. Refer to part 1, Silent Reflux and the Role of Pepsin here.
Silent reflux, or laryngopharyngeal reflux (LPR), presents unique challenges for healthcare providers, particularly when it comes to managing patients with coexisting gut health conditions.
Often overlooked due to its “silent” nature, LPR can have profound implications for gut health, especially with prolonged use of acid-suppressive therapies like proton pump inhibitors (PPIs).
As pelvic health professionals, understanding these potential impacts is crucial for guiding patients toward holistic and effective management strategies.
Long-Term Gut Health Implications
Microbiome Disruption
The gut microbiome plays a pivotal role in overall health, including gastrointestinal function, immune response, and even mood regulation. However, chronic use of PPIs to manage LPR can disrupt this delicate balance, leading to a decrease in beneficial bacteria like Lactobacillus and Bifidobacterium and an increase in potentially harmful bacteria.
This imbalance can increase the risk of small intestinal bacterial overgrowth (SIBO), irritable bowel syndrome (IBS), and gastrointestinal infections. For pelvic health practitioners working with clients with concurrent pelvic and gastrointestinal dysfunction, recognizing the signs of microbiome disruption is key to effective management.
Persistent Gastrointestinal Symptoms
Although PPIs can provide symptomatic relief, they may mask underlying gastrointestinal symptoms or even contribute to new symptoms such as bloating, nausea, and abdominal discomfort. Research suggests that conditions like gastritis and functional dyspepsia may develop or persist due to altered gut microbiota and reduced gastric acid secretion.
As pelvic health providers, a comprehensive patient history-including inquiries about long-term PPI use-is essential when evaluating persistent gut-related complaints.
Clinical Implications: Probiotics, Diagnostics, and Treatment Strategies
The Role of Probiotics
Probiotics are increasingly recognized for their role in mitigating the negative effects of PPIs on the gut microbiome. Research supports their use in helping restore the balance of gut bacteria, reduce gastrointestinal symptoms, and improve overall gut health in patients undergoing long-term PPI therapy. Consider recommending strains like Lactobacillus rhamnosus and Bifidobacterium longum for their evidence-backed benefits in maintaining a healthy gut environment.
Diagnostic and Treatment Strategies
Objective diagnostic tools, such as pH and impedance monitoring, are invaluable for accurately diagnosing LPR and assessing the extent of reflux. For patients on chronic PPI therapy, these tools can help determine the necessity of ongoing treatment and inform more targeted, less invasive management approaches.
As pelvic health specialists, partnering with gastroenterologists or ENT professionals for comprehensive diagnostic evaluations can significantly enhance patient outcomes.
Incorporating ENT Endoscopy in Practice
Endoscopic evaluation of the laryngopharyngeal region can reveal subtle signs of reflux-related changes, such as erythema, granulomas, or subglottic edema. For patients presenting with persistent throat clearing, voice changes, or sensation of a lump in the throat (“globus pharyngeus”), endoscopy can provide definitive visual confirmation of LPR.
This diagnostic clarity enables more personalized treatment plans, potentially reducing the need for long-term pharmacologic management and emphasizing lifestyle and dietary modifications instead.
Non-Pharmacologic Approaches for LPR Management
Dietary Interventions
Dietary management is a cornerstone of LPR care, emphasizing the reduction of foods with a pH lower than 3.5 (e.g., citrus fruits, tomatoes, and coffee). Beyond this, diets high in dietary fiber and low in sugar and fat have been shown to improve gut health and reduce symptoms. Incorporating functional foods like high-fiber vegetables, fermented foods (e.g., sauerkraut, kefir), and prebiotic-rich foods (e.g., garlic, onions) can support a healthy gut microbiome and reduce dependence on acid suppressants.
Functional Foods to Consider:
- Probiotic-Rich: Yogurt, kefir, miso, sauerkraut, kimchi
- Prebiotic-Rich: Asparagus, garlic, leeks, onions, oats, and bananas
- Alkaline Foods: Leafy greens, cucumber, melons, and certain legumes
For pelvic health providers, this knowledge can be integrated into patient education and coaching, emphasizing the impact of nutrition on both gut and pelvic health.
The Importance of Chewing and Meal Timing
Encouraging patients to eat slowly and chew food thoroughly can significantly reduce reflux symptoms. Proper mastication stimulates digestive enzymes and reduces the risk of incomplete digestion, which can exacerbate reflux. Additionally, advising patients to eat at least 4 hours before bedtime minimizes the risk of nighttime reflux. Elevating the head of the bed or using a wedge pillow can also reduce symptoms for those with nocturnal LPR.
Conclusion: A Balanced Approach for Optimal Health
While PPIs are highly effective in managing the symptoms of silent reflux in the acute phase or short term, their long-term use can lead to significant disruptions in gut health. Pelvic health providers can play a critical role in supporting patients through dietary modifications, incorporating probiotics, and using non-pharmacological strategies to promote overall gut health and well-being. By taking a holistic approach, providers can help mitigate the long-term impacts of silent reflux and enhance the quality of life for their patients.
References:
Herdiana Y. Functional Food in Relation to Gastroesophageal Reflux Disease (GERD). Nutrients. 2023; 15(16):3583. https://doi.org/10.3390/nu15163583
Liu, W., Xie, Y., Li, Y. et al. Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole. BMC Gastroenterol 22, 255 (2022). https://doi.org/10.1186/s12876-022-02320-y
Tahmina Lata, Jodie Trautman, Philip Townend, Robert B Wilson, Current management of gastro-oesophageal reflux disease-treatment costs, safety profile, and effectiveness: a narrative review, Gastroenterology Report, Volume 11, 2023, goad008, https://doi.org/10.1093/gastro/goad008
Fossmark, R., Ness-Jensen, E. & Sørdal, Ø. Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?. BMC Gastroenterol 23, 303 (2023). https://doi.org/10.1186/s12876-023-02945-7